These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 28452864

  • 1. Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone.
    Coulthard SA, Berry P, McGarrity S, McLaughlin S, Ansari A, Redfern CPF.
    Inflamm Bowel Dis; 2017 Jun; 23(6):946-955. PubMed ID: 28452864
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
    Kiszka-Kanowitz M, Theede K, Nielsen AM.
    Ugeskr Laeger; 2014 May 26; 176(22):. PubMed ID: 25352005
    [Abstract] [Full Text] [Related]

  • 6. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
    Kiszka-Kanowitz M, Theede K, Nielsen AM.
    Ugeskr Laeger; 2015 Jun 22; 177(26):1253-5. PubMed ID: 26550625
    [Abstract] [Full Text] [Related]

  • 7. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH.
    Aliment Pharmacol Ther; 2010 Mar 22; 31(6):640-7. PubMed ID: 20015102
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
    Wall GC, Muktar H, Effken C, Mahajan PB.
    Pharmacotherapy; 2018 Feb 22; 38(2):259-270. PubMed ID: 29197117
    [Abstract] [Full Text] [Related]

  • 10. Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations.
    Curkovic I, Rentsch KM, Frei P, Fried M, Rogler G, Kullak-Ublick GA, Jetter A.
    Eur J Clin Pharmacol; 2013 Aug 22; 69(8):1521-31. PubMed ID: 23588559
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.
    Vasudevan A, Beswick L, Friedman AB, Moltzen A, Haridy J, Raghunath A, Sparrow M, van Langenberg D.
    Dig Liver Dis; 2018 Jul 22; 50(7):682-688. PubMed ID: 29525182
    [Abstract] [Full Text] [Related]

  • 14. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.
    Smith MA, Blaker P, Marinaki AM, Anderson SH, Irving PM, Sanderson JD.
    J Crohns Colitis; 2012 Oct 22; 6(9):905-12. PubMed ID: 22386736
    [Abstract] [Full Text] [Related]

  • 15. Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.
    Min MX, Weinberg DI, McCabe RP.
    J Clin Pharm Ther; 2014 Apr 22; 39(2):107-11. PubMed ID: 24438369
    [Abstract] [Full Text] [Related]

  • 16. Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.
    Leong RW, Gearry RB, Sparrow MP.
    Expert Opin Drug Saf; 2008 Sep 22; 7(5):607-16. PubMed ID: 18759713
    [Abstract] [Full Text] [Related]

  • 17. Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.
    Lee MN, Kang B, Choi SY, Kim MJ, Woo SY, Kim JW, Choe YH, Lee SY.
    Inflamm Bowel Dis; 2015 May 22; 21(5):1054-62. PubMed ID: 25851563
    [Abstract] [Full Text] [Related]

  • 18. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
    Seinen ML, van Asseldonk DP, de Boer NK, Losekoot N, Smid K, Mulder CJ, Bouma G, Peters GJ, van Bodegraven AA.
    J Crohns Colitis; 2013 Nov 22; 7(10):812-9. PubMed ID: 23317929
    [Abstract] [Full Text] [Related]

  • 19. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ.
    Scand J Gastroenterol Suppl; 1998 Nov 22; 225():92-9. PubMed ID: 9515759
    [Abstract] [Full Text] [Related]

  • 20. A skewed thiopurine metabolism is a common clinical phenomenon that can be successfully managed with a combination of low-dose azathioprine and allopurinol.
    Appell ML, Wagner A, Hindorf U.
    J Crohns Colitis; 2013 Jul 22; 7(6):510-3. PubMed ID: 23168376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.